ＪＣＲファーマ：JCR Announces Completion of the Phase 1/2 Clinical Trial Notification of JR-171 for mucopolysaccharidosis type I (MPS-Phase 1/2 clinical trial is e I) - 有報キャッチャー

ＪＣＲファーマ（4552）　JCR Announces Completion of the Phase 1/2 Clinical Trial Notification of JR-171 for mucopolysaccharidosis type I (MPS-Phase 1/2 clinical trial is e I) 2020/07/31

/-

読み込み中…